Anti-glutamic acid decarboxylase (GAD) antibodies have been associated with type 1 diabetes mellitus and a large variety of neurological conditions, including epilepsy (1).
GAD antibodies are also associated with other conditions such as Stiff Man syndrome.
The background frequency of anti-GAD antibodies in the general population has been assessed to be around 0.4-1% (2)
Reference:
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page